Further, we also found the down regulation of anti-apoptotic molecules BCL-2, Bcl-xL, cIAP2, XIAP, Axin2 and Survivin in the AKAP4-depleted CRC cells indicating that AKAP4 may be potential therapeutic target in cancer management. This evidence concerns the gene BCL2 and colorectal carcinoma.